Emma Vidal: A new bispecific DC-T cell engager designed to potentiate aPD-1 immunotherapy

Emma Vidal, Founder of DrawImpacts, shared an X post by Rony Dahan, Principal Investigator at Weizmann Institute of Science, adding:

“We had a blast working with the Rony Dahan and Yuval Shapir Itai to illustrate their latest paper on BiCE (Bispecific DC-T Cell Engager), a new bispecific DC-T cell engager designed to potentiate aPD-1 immunotherapy!

Learn more about their amazing work.”

Quoting Rony Dahan‘s post:

“Together with IdoAmitLab we’re very excited to introduce BiCE (Bispecific DC-T Cell Engager)- a new platform to engineer immune cell communication for cancer immunotherapy. Led by the amazing Yuval Shapir Itai, Oren Barboy, now out in Cell Press Journal.”

Source: Emma Vidal/X and Rony Dahan/X